GE HealthCare Technologies Inc.
GEHC Healthcare Medical Devices
GE HealthCare Technologies Inc.’s revenue for fiscal 2025 (year ended December 2025) was $20.6 billion, up 4.84% from fiscal 2024. In the quarter to June 2026, revenue grew 5.75%, EPS grew 17.0%, free cash flow grew 750.0% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; dividend growth for three consecutive years, revenue growth for five; insiders bought in the last twelve months.
Follow GEHC
GE HealthCare Technologies Inc. (GEHC) EBITDA
GE HealthCare Technologies Inc.'s EBITDA for fiscal 2025 was $3.3B, unchanged from fiscal 2024. Over the twelve months to 30 June 2026 it was $3.3B. Over the past ten years it has ranged from $2.8B (fiscal 2019) to $3.4B (fiscal 2021); the current reading is higher than 71% of that period. GE HealthCare Technologies Inc. ranks 6th of 147 Medical Devices companies by EBITDA.
EBITDA, annual
Embed this chart
Annual newest first
| Period | EBITDA | Change |
|---|---|---|
| FY2025 | $3.3B | 4.21% |
| FY2024 | $3.2B | 5.25% |
| FY2023 | $3.0B | (3.49%) |
| FY2022 | $3.2B | (7.75%) |
| FY2021 | $3.4B | 2.09% |
| FY2020 | $3.4B | 20.37% |
| FY2019 | $2.8B | — |
Quarterly newest first
| Period | EBITDA | Change |
|---|---|---|
| Jun 2026 | $899.0M | 34.58% |
| Mar 2026 | $668.0M | (31.49%) |
| Dec 2025 | $975.0M | 21.88% |
| Sep 2025 | $800.0M | (0.12%) |
| 14 more quarters | Free account |
Against its own ten years
EBITDA against peers
| Company | EBITDA |
|---|---|
| BSX Boston Scientific Corporation compare | $5.6B |
| PHG Koninklijke Philips N.V. compare | $3.4B |
| GEHC GE HealthCare Technologies Inc. | $3.3B |
| SNN Smith & Nephew SNATS, Inc. compare | $2.6B |
| ZBH Zimmer Biomet Holdings, Inc. compare | $2.3B |
| STE STERIS plc compare | $1.6B |
| EW Edwards Lifesciences Corporation compare | $1.6B |
| DXCM DexCom, Inc. compare | $1.4B |
| PEN Penumbra, Inc. compare | $204.5M |
What EBITDA is
EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.
Reported line item
More on GEHC
- Revenue
- Net income
- EPS (diluted)
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement